Marisa MinettiHead of Late Phase Clinical Trial Administration, Chiesi Group |
|
Jenny ZecchiniClinical Research Department Director, CROMSOURCE |
|
Rob JonesDirector, Professional Services, Phlexglobal |
Regulators have made it abundantly clear - through recent guidance and inspection findings - that demonstrating sponsor oversight of an outsourced study is a critical requirement for TMF health and inspection-readiness. Watch this webinar to discover how global biopharmaceutical company Chiesi and its CRO partners collaborate to ensure ongoing oversight compliance, in the face of increasing documentation requirements and trial complexity.